–Editor’s Comment: At seven minutes into the video Dr. Sayed describes Neurological symptoms which he is experiencing and which are preventing his completion of a protocol therapy for Long Haulers for Dr. Peter Cory and the FLCCC. Sadly, he does not connect these symptoms to the Moderna Vaccine which he took in two doses not long ago.
1 / 3 – Summary of the Israeli People’s Committee’s database regarding adverse events related to the covid-19 vaccine in Israel: Updated until May 11th, 2021
Neurology:
Neurological impairment (vertigo, paresthesia, Facial nerve palsy, paralysis)Bell’s Palsy; Neurological-motor impairment (limb paralysis); Seizure; Neurological-cranial impairment; Other (cognitive impairment, neurological-sensory impairment, intracranial pressure, ageus, ALS See PDF
************************************************************************
08V2021 version 3 Expert evaluation on adverse effects of the Pfizer-COVID-19 vaccination Institute of Microstructure Technology, Karlsruhe Institute of Technology (KIT)
Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany; podarcissicula@gmail.com
I, Hervé Seligmann, am writing this evaluation at the request of several people all over the world, for submission to any Court worldwide.
Overview: Any medical treatment must be evaluated along a cost-benefit analysis. No treatment is risk free. It is in this respect that transparent availability of risk-group-stratified data on potential effects of vaccination, as compared to corresponding unvaccinated groups, must be available. These should be analysed by specialists free of any suspicions of conflicts of interests. The publication and unbiased discussion of their results must be facilitated, not hindered. Below I describe several potential negative vaccine effects, including vaccination-associated, documented 3- and 20-fold increases in infection and death rates, respectively. These cast serious doubts on positive outcomes of the above-mentioned cost-benefit analysis, which seems absent from public discourse. Further analyses show for ages 20-90 that increases in vaccination-associated mortality are inversely proportional to age, up to 60 % for those aged 20-24. Extrapolating these results for ages below 20 expects mortality increases beyond 100 % for those younger than 5. It is essential to account for adverse vaccine effects during the period of vaccination. Most publications on COVID19-vaccination in Israel only refer to the period after full vaccination. This is misleading and tantamount to only tell cancer patients their survival rates after they survived a successful treatment. Standard estimations of treatment success include risks during the treatment, which is often a period of increased risks, as suggested below.
**********
**********************************************************
The Rapid Mass Deployment of COVID–19 Vaccinations and Its Possible Biological Effects on the Population: A Special Interview With Stephanie Seneff, Ph.D.,By Dr. Joseph Mercola
*************************************************************
Stephanie Seneff: Prions and Protein Misfolding
